EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade

Masafumi Shimojo iD, Yasuya Inden, Taiki Kitahara, Shotaro Hiramatsu iD, Yuki Tanaka, Takehiro Hiramatsu, Taishi Fukushima, Kentaro Adachi, Tsubasa Teraoka, Ryusuke Ota, Satoshi Yanagisawa iD, Yukiomi Tsuji

Journal of Cardiovascular Electrophysiology · 2026-08 · 37 (8) · 1808-1816

DOI: 10.1111/jce.70415 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 25.06.2026. Verfasst von Masafumi Shimojo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Research and Innovation, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Cardiac Tamponade, Factor Xa, Blood Coagulation, Factor Xa Inhibitors. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Procedure‐related cardiac tamponade remains a serious complication of invasive arrhythmia procedures. Although andexanet alfa has been used for refractory pericardial bleeding in patients receiving factor Xa inhibitors, little is known about temporal changes in coagulation biomarkers after its administration in this setting. Methods and Results We conducted a single‐center retrospective observational study of 15 patients with cardiac tamponade secondary to procedure‐related cardiac injury between January 2019 and December 2025. Patients were classified according to andexanet alfa use during tamponade management. Coagulation parameters were evaluated at predefined time points from before tamponade onset through day three. Analyses were primarily descriptive. Of the 15 patients, four were treated with andexanet alfa and 11 were managed without andexanet alfa. All patients in the andexanet alfa group were receiving edoxaban for atrial fibrillation. Hemostasis was achieved in all patients after andexanet alfa administration. Patients treated with andexanet alfa showed a distinctive temporal biomarker pattern, characterized by a more pronounced rise in thrombin‐antithrombin complex and prothrombin fragment 1 + 2 at the early post‐hemostasis time point, whereas D‐dimer showed little apparent change at this time point and appeared to be higher on day one. No thromboembolic complications occurred in the andexanet alfa group during hospitalization.

Conclusion

In this small descriptive cohort, andexanet alfa administration was followed by prompt hemostasis in all treated patients, while also being accompanied by early increases in thrombin‐generation markers and later evidence of fibrin turnover. These hypothesis‐generating findings support careful use of andexanet alfa as rescue therapy with attention to potential early procoagulant changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac TamponadeFactor XaBlood CoagulationFactor Xa InhibitorsCardiac Surgical ProceduresHumansBiomarkersRecombinant ProteinsRetrospective StudiesFemaleMaleTime FactorsTreatment OutcomeAgedMiddle AgedPeptide FragmentsFibrin Fibrinogen Degradation ProductsAntithrombin IIIPeptide HydrolasesProthrombin

Stichwörter der Autor:innen

andexanet alfacardiac tamponadecatheter ablationcoagulation biomarkersfactor Xa inhibitor

Substanzen

BiomarkersRecombinant ProteinsFactor XaPRT064445Factor Xa InhibitorsPeptide FragmentsFibrin Fibrinogen Degradation Productsprothrombin fragment 1.2antithrombin III-protease complexfibrin fragment D

Autor:innen und Institutionen

  • Department of Cardiovascular Research and Innovation, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

ORCID-Profile: Masafumi Shimojo, Shotaro Hiramatsu, Satoshi Yanagisawa

Zitieren

APA

Shimojo, M., Inden, Y., Kitahara, T., Hiramatsu, S., Tanaka, Y., Hiramatsu, T., Fukushima, T., Adachi, K., Teraoka, T., Ota, R., Yanagisawa, S., & Tsuji, Y. (2026). Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade. Journal of Cardiovascular Electrophysiology, 37(8), 1808-1816. https://doi.org/10.1111/jce.70415

Vancouver

Shimojo M, Inden Y, Kitahara T, Hiramatsu S, Tanaka Y, Hiramatsu T, et al. Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade. Journal of Cardiovascular Electrophysiology. 2026;37(8):1808-1816. doi:10.1111/jce.70415

BibTeX
@article{Shimojo2026,
  author = {Shimojo, Masafumi and Inden, Yasuya and Kitahara, Taiki and Hiramatsu, Shotaro and Tanaka, Yuki and Hiramatsu, Takehiro and Fukushima, Taishi and Adachi, Kentaro and Teraoka, Tsubasa and Ota, Ryusuke and Yanagisawa, Satoshi and Tsuji, Yukiomi},
  title = {Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {8},
  pages = {1808--1816},
  doi = {10.1111/jce.70415}
}
Kostenlos starten →